Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 1,384 Cr.
 - Current Price ₹ 270
 - High / Low ₹ 409 / 145
 - Stock P/E
 - Book Value ₹ 151
 - Dividend Yield 0.00 %
 - ROCE 5.50 %
 - ROE -0.41 %
 - Face Value ₹ 10.0
 
Pros
- Company has reduced debt.
 - Debtor days have improved from 34.6 to 25.5 days.
 
Cons
- Company has low interest coverage ratio.
 - The company has delivered a poor sales growth of 5.05% over past five years.
 - Company has a low return on equity of 1.28% over last 3 years.
 
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 1,449 | 1,526 | 1,691 | 2,000 | 1,675 | 1,853 | 1,860 | |
| 1,347 | 1,372 | 1,560 | 1,861 | 1,544 | 1,753 | 1,742 | |
| Operating Profit | 102 | 155 | 131 | 139 | 132 | 100 | 118 | 
| OPM % | 7% | 10% | 8% | 7% | 8% | 5% | 6% | 
| 13 | 7 | 6 | 6 | 14 | 16 | 14 | |
| Interest | 68 | 72 | 60 | 73 | 76 | 72 | 67 | 
| Depreciation | 45 | 47 | 48 | 50 | 60 | 50 | 51 | 
| Profit before tax | 2 | 43 | 29 | 23 | 10 | -5 | 14 | 
| Tax % | -53% | 43% | 44% | 49% | -2% | -51% | |
| 3 | 25 | 16 | 12 | 11 | -3 | -17 | |
| EPS in Rs | 0.60 | 5.86 | 3.89 | 2.86 | 2.52 | -0.52 | -6.60 | 
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % | 
| 5 Years: | 5% | 
| 3 Years: | 3% | 
| TTM: | 6% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % | 
| 5 Years: | -48% | 
| 3 Years: | % | 
| TTM: | -281% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | % | 
| 5 Years: | % | 
| 3 Years: | % | 
| 1 Year: | -23% | 
| Return on Equity | |
|---|---|
| 10 Years: | % | 
| 5 Years: | 2% | 
| 3 Years: | 1% | 
| Last Year: | 0% | 
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 | 
| Reserves | 392 | 416 | 432 | 442 | 452 | 721 | 
| 584 | 564 | 634 | 739 | 655 | 488 | |
| 419 | 417 | 625 | 517 | 838 | 683 | |
| Total Liabilities | 1,437 | 1,440 | 1,734 | 1,740 | 1,987 | 1,944 | 
| 733 | 706 | 666 | 866 | 849 | 862 | |
| CWIP | 17 | 9 | 50 | 17 | 29 | 38 | 
| Investments | 14 | 14 | 14 | 16 | 16 | 16 | 
| 673 | 711 | 1,004 | 842 | 1,093 | 1,028 | |
| Total Assets | 1,437 | 1,440 | 1,734 | 1,740 | 1,987 | 1,944 | 
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 240 | 129 | 40 | 185 | 196 | -1 | |
| -28 | -8 | -47 | -217 | -45 | -61 | |
| -211 | -120 | 7 | 31 | -151 | 63 | |
| Net Cash Flow | 0 | 0 | 1 | -1 | 1 | 0 | 
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 30 | 39 | 38 | 39 | 40 | 26 | 
| Inventory Days | 131 | 147 | 250 | 194 | ||
| Days Payable | 124 | 133 | 197 | 141 | ||
| Cash Conversion Cycle | 37 | 53 | 38 | 39 | 92 | 79 | 
| Working Capital Days | -69 | 0 | 4 | 3 | -17 | 18 | 
| ROCE % | 11% | 8% | 8% | 7% | 6% | 
Documents
Announcements
- 
        
          Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
          
            22h - Godavari Biorefineries Q2 & H1 FY26 earnings call on 14 Nov 2025 at 11:00 AM IST.
 - 
        
          Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended On September 30, 2025
          
            24h - Board meeting on 11 Nov 2025 to approve Q2/H1 unaudited results; trading window closed.
 - 
        
          Announcement under Regulation 30 (LODR)-Change in Directorate
          
            29 Oct - Mr. Sanjay Puri (DIN 08789423) ceases as Independent Director effective 30 October 2025.
 - 
        
          Announcement Under Regulation 30 Of SEBI (LODR) Regulation - Approval Of Patent Application
          
            16 Oct - European patent granted Oct 16, 2025 for anti-cancer compounds targeting cancer stem cells.
 - 
        
          Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
          
            15 Oct - MUFG Intime certificate under Reg 74(5) confirming demat processing for quarter ended 30 Sep 2025.
 
Annual reports
Concalls
- 
      Aug 2025Transcript PPT
 - 
      May 2025Transcript PPT REC
 - 
      May 2025TranscriptNotesPPT
 - 
      Feb 2025Transcript PPT REC
 - 
      Nov 2024Transcript PPT REC
 
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.